{
    "clinical_study": {
        "@rank": "52040", 
        "arm_group": [
            {
                "arm_group_label": "Hydros", 
                "arm_group_type": "Experimental", 
                "description": "Hydros Joint Therapy"
            }, 
            {
                "arm_group_label": "Hydros-TA", 
                "arm_group_type": "Experimental", 
                "description": "Hydros-TA Joint Therapy"
            }, 
            {
                "arm_group_label": "Triamcinolone acetonide", 
                "arm_group_type": "Active Comparator", 
                "description": "Triamcinolone acetonide"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the safety and efficacy of Hydros-TA Joint Therapy\n      for relief of pain due to OA of the knee.  Hydros-TA is designed to provide fast acting and\n      long lasting pain relief for up to six months with a single IA injection."
        }, 
        "brief_title": "Hydros and Hydros-TA Joint Therapy for Pain Associated With Knee Osteoarthritis", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Osteoarthritis of the Knee", 
        "condition_browse": {
            "mesh_term": [
                "Osteoarthritis", 
                "Osteoarthritis, Knee"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Have radiographic evidence within the prior 6 months, as shown in the radiology\n             reports, of OA grade 2 or 3 using Kellgren-Lawrence Grading for OA.\n\n          -  Symptoms in the index knee for at least 12 months.\n\n          -  Fully ambulatory Subject (ability to perform a 15 meters walk test).\n\n          -  Male and female Subjects 40 through 85 years of age.\n\n        Exclusion Criteria:\n\n          -  BMI >40 kg\n\n          -  Secondary OA (acute knee injury, rheumatoid arthritis, gout, history of joint\n             infection, osteonecrosis, chronic fibromyalgia) or other chronic autoimmune disease.\n\n          -  Intra articular steroid therapy in last 3 months\n\n          -  Intra articular viscosupplementation in last 6 months"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "510", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02022930", 
            "org_study_id": "COR1.1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Hydros", 
                "intervention_name": "Hydros", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Hydros-TA", 
                "intervention_name": "Hydros-TA", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Triamcinolone acetonide", 
                "intervention_name": "Triamcinolone Acetonide", 
                "intervention_type": "Drug", 
                "other_name": "Triamcinolone Acetonide"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Triamcinolone hexacetonide", 
                "Triamcinolone", 
                "Triamcinolone Acetonide", 
                "Triamcinolone diacetate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Osteoarthritis", 
            "Knee"
        ], 
        "lastchanged_date": "February 25, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "St.Leonards", 
                        "country": "Australia", 
                        "state": "New South Wales"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "Canada", 
                        "state": "Ontario"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oshawa", 
                        "country": "Canada"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Quebec City", 
                        "country": "Canada"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Willemstad", 
                        "country": "Netherlands Antilles", 
                        "state": "Curacao"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Australia", 
                "Canada", 
                "Netherlands Antilles"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "A Multi-center, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Hydros and Hydros-TA Joint Therapies for Management of Pain Associated With Osteoarthritis in the Knee", 
        "overall_contact": {
            "email": "mmaroney@carbylan.com", 
            "last_name": "Marcee Maroney", 
            "phone": "650 8556774"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Health Canada", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline in the WOMAC A subscale score for the treatment knee.", 
            "safety_issue": "No", 
            "time_frame": "2 weeks and 26 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02022930"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Strict positive responders to treatment for symptomatic primary osteoarthritis of the knee", 
            "safety_issue": "No", 
            "time_frame": "26 weeks"
        }, 
        "source": "Carbylan BioSurgery, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Carbylan BioSurgery, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}